HomeHealthcare & Life SciencesPharmaceuticals Sarcoidosis Therapeutics Market

India Sarcoidosis Therapeutics Market Size & Outlook, 2026-2034


India Sarcoidosis Therapeutics Market Insights

  • As per Reed Intelligence insights, the India Sarcoidosis Therapeutics Market stood at USD 57.08 Million in 2025 and is anticipated to grow to USD 119.37 Million by 2034.
  • The India market is expected to advance at a CAGR of 8.49% from 2026 through 2034.
  • In 2025, Corticosteroids accounted for the highest share of the Drug Class market size.
  • During the forecast period, Immunosuppressants is set to register the highest growth, making it the most lucrative Drug Class segment.

Other Key Findings


  • India contributed 4.02% to the global Sarcoidosis Therapeutics Market size in 2025.
  • By 2034, United States is forecasted to remain the largest global market for Sarcoidosis Therapeutics Market.
  • In Asia Pacific, China is projected to capture the leading share of market size by 2034.
  • Among Asia Pacific markets, Taiwan is expected to post the fastest growth, reaching USD 33.14 Million by 2034.

Report Summary

Report Scope Details
Base Year for Study 2025
Study Period 2022-2034
Historical Period 2022-2024
Forecast Period 2026-2034
Market Size In 2025 USD 57.08 Million
Market Size In 2034 USD 119.37 Million
Largest segment Corticosteroids
Units Revenue in USD Million
CAGR 8.49% (2026-2034)
Segmnetation Covered
Drug Class
  1. Corticosteroids
  2. Immunosuppressants
  3. Biologics
  4. Antimalarial Agents
Disease Type
  1. Pulmonary Sarcoidosis
  2. Cutaneous Sarcoidosis
  3. Cardiac Sarcoidosis
  4. Ocular Sarcoidosis
  5. Others
Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports